Literature DB >> 24240484

Comparison of minimally invasive versus open transforaminal lumbar interbody fusion in two-level degenerative lumbar disease.

Guangfei Gu1, Hailong Zhang, Guoxin Fan, Shisheng He, Xiaobing Cai, Xiaolong Shen, Xiaofei Guan, Xu Zhou.   

Abstract

PURPOSE: The purpose of this study was to compare the clinical and radiological outcomes of minimally invasive versus open transforaminal lumbar interbody fusion in two-level degenerative lumbar disease.
METHODS: We conducted a prospective cohort study of 82 patients, who underwent two-level minimally invasive or open transforaminal lumbar interbody fusion (TLIF) from March 2010 to December 2011. Forty-four patients underwent minimally invasive transforaminal lumbar interbody fusion (MITLIF) (group A) and 38 patients underwent the traditional open TLIF (group B). Demographic data and clinical characteristics were comparable between the two groups before surgery (p > 0.05). Peri-operative data, clinical and radiological outcomes between the two groups were compared.
RESULTS: The mean follow-up period was 20.6 ± 4.5 months for group A and 20.0 ± 3.3 months for group B (p > 0.05). No significant difference existed in operating time between the two group (p > 0.05). X-ray exposure time was significantly longer for MITLIF compared to open cases. Intra-operative blood loss and duration of postoperatively hospital stay of group A were significantly superior to those of group B (p < 0.05). On postoperative day three, MITLIF patients had significantly less pain compared to patients with the open procedure. No statistical difference existed in pre-operative and latest VAS value of back pain (VAS-BP) and leg pain (VAS-LP), pre-operative and latest ODI between the two groups. The fusion rate of the two groups was similar (p < 0.05). Complications included small dural tear, superficial wound infection and overlong screws. When comparing the total complications, no significant difference existed between the groups (p > 0.05).
CONCLUSIONS: MITLIF offers several potential advantages including postoperative back pain and leg pain, intra-operative blood loss, transfusion and duration of hospital stay postoperatively in treating two-level lumbar degenerative disease. However, it required much more radiation exposure.

Entities:  

Mesh:

Year:  2013        PMID: 24240484      PMCID: PMC3971284          DOI: 10.1007/s00264-013-2169-x

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  31 in total

1.  Advances in minimally invasive spine surgery.

Authors:  Kevin T Foley; Michael A Lefkowitz
Journal:  Clin Neurosurg       Date:  2002

2.  Minimally invasive versus open transforaminal lumbar interbody fusion: evaluating initial experience.

Authors:  Constantin Schizas; Nicolas Tzinieris; Elefterios Tsiridis; Victor Kosmopoulos
Journal:  Int Orthop       Date:  2008-11-21       Impact factor: 3.075

3.  Unilateral versus bilateral instrumented transforaminal lumbar interbody fusion in two-level degenerative lumbar disorders: a prospective randomised study.

Authors:  Kai Zhang; Wei Sun; Chang-qing Zhao; Hua Li; Wei Ding; You-zhuan Xie; Xiao-jiang Sun; Jie Zhao
Journal:  Int Orthop       Date:  2013-08-06       Impact factor: 3.075

4.  Unilateral posterior lumbar interbody fusion: simplified dowel technique.

Authors:  H G Blume
Journal:  Clin Orthop Relat Res       Date:  1985-03       Impact factor: 4.176

5.  Serial changes in trunk muscle performance after posterior lumbar surgery.

Authors:  R Gejo; H Matsui; Y Kawaguchi; H Ishihara; H Tsuji
Journal:  Spine (Phila Pa 1976)       Date:  1999-05-15       Impact factor: 3.468

6.  Regulating exposure of the lens of the eye to ionising radiations.

Authors:  M C Thorne
Journal:  J Radiol Prot       Date:  2012-05-03       Impact factor: 1.394

7.  Transforaminal lumbar interbody fusion: clinical and radiographic results and complications in 100 consecutive patients.

Authors:  Benjamin K Potter; Brett A Freedman; Eric G Verwiebe; Jordan M Hall; David W Polly; Timothy R Kuklo
Journal:  J Spinal Disord Tech       Date:  2005-08

8.  Comparison of one-level minimally invasive and open transforaminal lumbar interbody fusion in degenerative and isthmic spondylolisthesis grades 1 and 2.

Authors:  Jian Wang; Yue Zhou; Zheng Feng Zhang; Chang Qing Li; Wen Jie Zheng; Jie Liu
Journal:  Eur Spine J       Date:  2010-04-22       Impact factor: 3.134

9.  Anterior fresh frozen structural allografts in the thoracic and lumbar spine. Do they work if combined with posterior fusion and instrumentation in adult patients with kyphosis or anterior column defects?

Authors:  K H Bridwell; L G Lenke; K W McEnery; C Baldus; K Blanke
Journal:  Spine (Phila Pa 1976)       Date:  1995-06-15       Impact factor: 3.468

10.  Cancer risks attributable to low doses of ionizing radiation: assessing what we really know.

Authors:  David J Brenner; Richard Doll; Dudley T Goodhead; Eric J Hall; Charles E Land; John B Little; Jay H Lubin; Dale L Preston; R Julian Preston; Jerome S Puskin; Elaine Ron; Rainer K Sachs; Jonathan M Samet; Richard B Setlow; Marco Zaider
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

View more
  32 in total

1.  Perioperative outcomes in minimally invasive lumbar spine surgery: A systematic review.

Authors:  Branko Skovrlj; Patrick Belton; Hekmat Zarzour; Sheeraz A Qureshi
Journal:  World J Orthop       Date:  2015-12-18

Review 2.  Cost-utility of minimally invasive versus open transforaminal lumbar interbody fusion: systematic review and economic evaluation.

Authors:  Kevin Phan; Jarred A Hogan; Ralph J Mobbs
Journal:  Eur Spine J       Date:  2015-07-21       Impact factor: 3.134

3.  Ligament, nerve, and blood vessel anatomy of the lateral zone of the lumbar intervertebral foramina.

Authors:  Shi-Guo Yuan; You-Liang Wen; Pei Zhang; Yi-Kai Li
Journal:  Int Orthop       Date:  2015-07-02       Impact factor: 3.075

4.  Outcomes of percutaneous endoscopic trans-articular discectomy for huge central or paracentral lumbar disc herniation.

Authors:  Yu Wang; Yuqing Yan; Jin Yang; Lifeng Zhang; Chuan Guo; Zhiyu Peng; Hao Wu; Dongfeng Zhang; Qingquan Kong
Journal:  Int Orthop       Date:  2018-10-29       Impact factor: 3.075

Review 5.  Minimally invasive versus open transforaminal lumbar interbody fusion for treatment of degenerative lumbar disease: systematic review and meta-analysis.

Authors:  Kevin Phan; Prashanth J Rao; Andrew C Kam; Ralph J Mobbs
Journal:  Eur Spine J       Date:  2015-03-27       Impact factor: 3.134

Review 6.  Minimally invasive versus open transforaminal lumbar fusion: a systematic review of complications.

Authors:  Wei Hu; Jiandong Tang; Xianpei Wu; Li Zhang; Baoyi Ke
Journal:  Int Orthop       Date:  2016-03-18       Impact factor: 3.075

Review 7.  Clinical outcomes after minimally invasive transforaminal lumbar interbody fusion and lateral lumbar interbody fusion for treatment of degenerative lumbar disease: a systematic review and meta-analysis.

Authors:  Gun Keorochana; Kitipong Setrkraising; Patarawan Woratanarat; Alisara Arirachakaran; Jatupon Kongtharvonskul
Journal:  Neurosurg Rev       Date:  2016-12-24       Impact factor: 3.042

8.  Surgical training in spine surgery: safety and patient-rated outcome.

Authors:  Guy Waisbrod; Anne F Mannion; Támas F Fekete; Frank Kleinstueck; Deszö Jeszenszky; Daniel Haschtmann
Journal:  Eur Spine J       Date:  2019-01-29       Impact factor: 3.134

9.  Comparison of bilateral versus unilateral decompression incision of minimally invasive transforaminal lumbar interbody fusion in two-level degenerative lumbar diseases.

Authors:  Yongzhao Zhao; Yanjie Zhu; Hailong Zhang; Chuanfeng Wang; Shisheng He; Guangfei Gu
Journal:  Int Orthop       Date:  2018-05-13       Impact factor: 3.075

10.  Microendoscopy-assisted minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative disease: short-term and medium-term outcomes.

Authors:  Yang Yang; Bin Liu; Li-Min Rong; Rui-Qiang Chen; Jian-Wen Dong; Pei-Gen Xie; Liang-Ming Zhang; Feng Feng
Journal:  Int J Clin Exp Med       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.